Welcome to InfiCure Bio

InfiCure Bio is a life science company focusing on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions.

Based on a panel of in vivo models for these conditions including a proprietary model, the NIF mouse, for chronic inflammation and fibrosis, we offer effect tests of anti-inflammatory and anti-fibrotic drugs.

Founded on extensive experience and expertise in immunology, inflammation and fibrosis research, InfiCure Bio offers a proficient and flexible processing of drug validation projects in this area.

Contact us


NLSDays September 28-29

Sofia Mayans, CEO at Inficure Bio, will attend the annual Nordic Life Science Days in Malmö 28-29 September. We hope that you will meet Sofia in Malmö for fruitful discussions!